aspirin has been researched along with prostaglandin f1 in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (52.63) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Waitzman, MB | 1 |
| De la Cruz, JP; Garcia-Arnes, J; Pavia, J; Sanchez de la Cuesta, F | 1 |
| Herman, CA; Herman, RP | 1 |
| Bevan, J; Hanley, SP | 1 |
| Crawford, DD; Gimbrone, MA; Schafer, AI | 1 |
| Greaves, M; Jackson, CA; Preston, FE | 1 |
| Hansen, DG; Kauffman, GL; Ligumsky, M | 1 |
| Kiistala, U; Oikarinen, A; Rytsälä, H; Viinikka, L; Ylikorkala, O | 1 |
| Crampton, JM; Martinez, TT | 1 |
| Filabozzi, P; Patrignani, P; Patrono, C | 1 |
| Schirner, M; Taube, C | 1 |
| Hayashi, S; Kobayashi, T; Negita, M; Takagi, H; Uchida, K; Yasutomi, M; Yokoyama, I | 1 |
| Abendroth, D; Mickley, V; Schilling, M; Storck, M; Techt, B | 1 |
| Cyrus, T; FitzGerald, GA; Li, H; Praticò, D | 1 |
| Bing, RJ; Ingram, M; Miyataka, M; Rich, KA; Yamamoto, T | 1 |
| Claycombe, K; Kim, S; Moustaid-Moussa, N; Reath, DB; Whelan, J | 1 |
| Jiang, D; Liu, H; Ou, B; Zhang, S | 1 |
| Chau, K; Hennessy, A; Makris, A; Pears, S; Shanmugalingam, R; Xu, B | 1 |
| Han, M; Han, N; Liu, Z; Lv, G; Song, Z; Yin, J; Yu, B; Zhou, J | 1 |
1 review(s) available for aspirin and prostaglandin f1
| Article | Year |
|---|---|
Proposed metabolic dysfunctions in diabetic microthromboses and microangiopathy.
Topics: Alprostadil; Aspirin; Blood Platelets; Calcimycin; Collagen; Cyclic AMP; Cyclic GMP; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Dinoprost; Dinoprostone; Humans; Indomethacin; Models, Biological; Platelet Aggregation; Prostaglandins; Prostaglandins E; Prostaglandins F; Thromboxane A2 | 1979 |
2 trial(s) available for aspirin and prostaglandin f1
| Article | Year |
|---|---|
Prostacyclin, thromboxane and prostaglandin F2 alpha in suction blister fluid of human skin: effect of systemic aspirin and local glucocorticosteroid treatment.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Betamethasone; Blister; Clobetasol; Dinoprost; Epoprostenol; Exudates and Transudates; Humans; Male; Prostaglandins; Prostaglandins F; Skin; Thromboxane A2; Thromboxane B2; Thromboxanes | 1981 |
Influence of systemic cyclooxygenase inhibition with single-dose aspisol on kinetics of arachidonic acid metabolites in the venous effluate of transplanted kidney grafts in humans.
Topics: Adult; Arachidonic Acids; Aspirin; Creatinine; Cyclooxygenase Inhibitors; Enzyme-Linked Immunosorbent Assay; Female; Histocompatibility Testing; Humans; Kidney Transplantation; Leukotriene B4; Lysine; Male; Middle Aged; Prostaglandins F; Thromboxane B2 | 1996 |
16 other study(ies) available for aspirin and prostaglandin f1
| Article | Year |
|---|---|
Effects of triflusal and acetylsalicylic acid on platelet aggregation in whole blood of diabetic patients.
Topics: Adult; Aspirin; beta-Thromboglobulin; Diabetes Mellitus, Type 1; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandins F; Salicylates; Thromboxane B2 | 1988 |
Prostaglandins or prostaglandin like substances are implicated in normal growth and development in oomycetes.
Topics: Alprostadil; Aspirin; Dinoprost; Dose-Response Relationship, Drug; Fatty Acids; Fungi; Indomethacin; Oomycetes; Prostaglandins; Prostaglandins E; Prostaglandins F | 1985 |
Inhibition by aspirin of human arterial and venous prostacyclin synthesis.
Topics: Administration, Oral; Adult; Aged; Aspirin; Epoprostenol; Female; Humans; Male; Mesenteric Arteries; Mesenteric Veins; Middle Aged; Prostaglandin Antagonists; Prostaglandins F | 1985 |
Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Calcimycin; Cattle; Cell Communication; Endothelium; Epoprostenol; Humans; Muscle, Smooth, Vascular; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandins F; Thromboxane B2 | 1984 |
A study of the stimulation of human venous prostacyclin synthesis by dipyridamole.
Topics: Aspirin; Dipyridamole; Dose-Response Relationship, Drug; Epoprostenol; Humans; Platelet Aggregation; Prostaglandins; Prostaglandins F; Stimulation, Chemical; Veins | 1982 |
Salicylic acid blocks indomethacin- and aspirin-induced cyclo-oxygenase inhibition in rat gastric mucosa.
Topics: Animals; Aspirin; Cyclooxygenase Inhibitors; Dinoprost; Drug Interactions; Gastric Mucosa; Indomethacin; Male; Prostaglandin Antagonists; Prostaglandins F; Rats; Rats, Inbred Strains; Salicylates; Salicylic Acid | 1982 |
Prostaglandins show marked differences when tested against early ischemic dysrhythmias in rat.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Aspirin; Blood Pressure; Coronary Disease; Dinoprostone; Epoprostenol; Male; Prostaglandins; Prostaglandins E; Prostaglandins F; Quinidine; Rats | 1981 |
Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects.
Topics: Adolescent; Adult; Aspirin; Blood Platelets; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Female; Humans; Male; Prostaglandins E; Prostaglandins F; Renin; Thromboxane B2; Thromboxanes | 1982 |
U 46619 induces different blood pressure effects in male and female spontaneously hypertensive rats (SHR).
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Administration, Oral; Animals; Aorta; Aspirin; Blood Pressure; Drug Synergism; Female; Injections, Intravenous; Male; Prostaglandin Endoperoxides, Synthetic; Prostaglandins F; Rats; Rats, Inbred SHR; Thromboxane B2; Vasoconstrictor Agents | 1993 |
Prevention of experimental hepatic metastasis with thromboxane synthase inhibitor.
Topics: Animals; Aspirin; Colonic Neoplasms; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Liver Neoplasms, Experimental; Male; Methacrylates; Mice; Mice, Inbred C57BL; Prostaglandins F; Thromboxane B2; Thromboxane-A Synthase | 1995 |
Endogenous biosynthesis of thromboxane and prostacyclin in 2 distinct murine models of atherosclerosis.
Topics: Age Factors; Animals; Aorta; Arteriosclerosis; Aspirin; Diet, Atherogenic; Disease Models, Animal; Eicosanoids; Epoprostenol; Female; Hominidae; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandins F; Receptors, LDL; Thromboxane A2; Thromboxane B2 | 2000 |
Nitric oxide, anti-inflammatory drugs on renal prostaglandins and cyclooxygenase-2.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Isoenzymes; Kidney; Male; Nitrates; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Prostaglandins F; Pyrazoles; Rabbits; Salicylates; Sulfonamides; Thromboxane B2 | 2002 |
Angiotensin II increases leptin secretion by 3T3-L1 and human adipocytes via a prostaglandin-independent mechanism.
Topics: 3T3 Cells; Adipocytes; Adipose Tissue; Angiotensin II; Animals; Aspirin; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Gene Expression Regulation; Humans; Indomethacin; Kinetics; Leptin; Mice; Prostaglandins; Prostaglandins F; Time Factors | 2002 |
Aspirin inhibits fractalkine expression in atherosclerotic plaques and reduces atherosclerosis in ApoE gene knockout mice.
Topics: Animals; Aorta; Apolipoproteins E; Aspirin; Atherosclerosis; C-Reactive Protein; Chemokine CX3CL1; Cholesterol; Cyclooxygenase 1; Cyclooxygenase 2; Dietary Fats; Gene Expression; Male; Membrane Proteins; Mice; Mice, Knockout; Prostaglandins F; Thromboxane B2; Triglycerides | 2010 |
The effect of acetyl salicylic acid (Aspirin) on trophoblast-endothelial interaction in vitro.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Communication; Cells, Cultured; Coculture Techniques; Endothelial Cells; Female; Humans; Microvessels; Myometrium; Pre-Eclampsia; Pregnancy; Prostaglandins F; Trophoblasts; Tumor Necrosis Factor-alpha | 2017 |
Evaluation of the antithrombotic activity of Zhi-Xiong Capsules, a Traditional Chinese Medicinal formula, via the pathway of anti-coagulation, anti-platelet activation and anti-fibrinolysis.
Topics: Acute Disease; Animals; Anticoagulants; Antithrombins; Aspirin; Blood Coagulation; Capsules; Carotid Arteries; Chlorides; Disease Models, Animal; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Ferric Compounds; Fibrinolysis; Heparin; Lung; Mice; Platelet Activation; Platelet Aggregation; Prostaglandins F; Pulmonary Embolism; Rabbits; Rats, Sprague-Dawley; Thrombolytic Therapy; Thrombosis; Thromboxane B2 | 2018 |